hold
360 results
1 - 100
sirolimus (protein bound)- zilucoplan
- dacomitinib
- loncastuximab tesirine
- lorlatinib
- elacestrant
- inavolisib
- eflornithine (systemic)
- lurbinectedin
- brigatinib
- selinexor
- PONATinib
- Administering Medications to Children
- crizotinib
- pomalidomide
- copanlisib
- teclistamab
- enfortumab vedotin
- beta blockers
- indacaterol
- abemaciclib
- fedratinib
- linaCLOtide
- ado-trastuzumab
- capmatinib
- lenvatinib
- entrectinib
- plecanatide
- lenalidomide
- erlotinib
- donanemab
- tepotinib
- axitinib
- ceritinib
- SORAfenib
- duvelisib
- ensartinib
- fam-trastuzumab deruxtecan
- cabozantinib
- capivasertib
- epcoritamab
- palbociclib
- ripretinib
- cabazitaxel
- avapritinib
- futibatinib
- talquetamab
- avalglucosidase alfa
- iptacopan
- tisotumab vedotin
- denileukin diftitox
- lazertinib
- dostarlimab
- elafibranor
- vadadustat
- tucatinib
- fruquintinib
- tremelimumab
- durvalumab
- SUNItinib
- panitumumab
- pegunigalsidase alfa
- ocrelizumab/hyaluronidase
- laronidase
- dextromethorphan
- umeclidinium
- lebrikizumab
- erdafitinib
- calaspargase pegol
- tagraxofusp
- ropeginterferon alfa-2b
- encorafenib
- binimetinib
- carfilzomib
- avelumab
- nivolumab
- efgartigimod alfa/hyaluronidase
- capecitabine
- trametinib
- cemiplimab
- Medication Administration Techniques
- cobimetinib
- datopotamab deruxtecan
- dabrafenib
- pegaspargase
- ruxolitinib (topical)
- somapacitan
- upadacitinib
- bevacizumab
- ipilimumab
- amivantamab
- tinzaparin
- trilaciclib
- ramucirumab
- everolimus
- necitumumab
- faricimab
- olutasidenib
- tofersen
- tiotropium